FDA Approves Updated Indication for Winrevair (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO Group 1 Pulmonary Hypertension)

Oct 31, 2025 - 08:00
 0  1
RAHWAY, N.J.--(BUSINESS WIRE) October 27, 2025 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0